Skip to main content

Texas Biologics logo

☰

  • Home
  • About
    • Overview
    • What are Biologics?
    • Executive Committee
    • News
  • Research
    • Our Approach
    • Current Projects
    • Core Facilities
    • Advanced Protein Therapeutics Core
  • Programs
    • Pilot Grants
    • Core Facility Support
    • Clinical Trials Unit
    • Biology & Machine Learning
  • Commercialization
    • Therapeutics Pipeline
    • Technology Partnering
    • Commercialization Partners
    • Resources for Faculty and Students
  • Get Involved
    • Partner with Us
    • Prospective Students
    • Giving
    • Contact
  • Events
  • Home
  • About
    • Overview
    • What are Biologics?
    • Executive Committee
    • News
  • Research
    • Our Approach
    • Current Projects
    • Core Facilities
    • Advanced Protein Therapeutics Core
  • Programs
    • Pilot Grants
    • Core Facility Support
    • Clinical Trials Unit
    • Biology & Machine Learning
  • Commercialization
    • Therapeutics Pipeline
    • Technology Partnering
    • Commercialization Partners
    • Resources for Faculty and Students
  • Get Involved
    • Partner with Us
    • Prospective Students
    • Giving
    • Contact
  • Events

↑

About

About

  • Overview
  • What are Biologics?
  • Executive Committee
  • News
    • In the Media

News

Ultrasound-based Drug Delivery Method Could Lead to Safer, Targeted Treatments

Details
February 05, 2025

 

UT Vaccine Scientist Will Be Inducted Into National Inventors Hall of Fame

Details
January 16, 2025

 

This Enzyme Plays a Key Role in Protecting Cells from Aging and Disease

Details
November 18, 2024

 

Researchers Identify Promising Combination Therapy for Common Blood Cancer

Details
October 11, 2024

 

Turbocharging Protein Engineering with AI

Details
October 09, 2024

 

AI Trained on Evolution’s Playbook Develops Proteins That Spur Drug and Scientific Discovery

Details
September 25, 2024

A new artificial intelligence model developed by researchers at The University of Texas at Austin paves the way for more effective and less toxic treatments and new preventive strategies in medicine.

Newly Discovered Antimicrobial Could Prevent or Treat Cholera

Details
September 11, 2024

More than a million people each year die from infections by pathogens that are resistant to antimicrobials, and the problem is growing. Meanwhile, the discovery of new antimicrobials that can help stem the tide has not kept pace.

Newly Discovered Antibody Protects Against All COVID-19 Variants

Details
September 03, 2024

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals.

How AI is Accelerating Discovery

Details
August 01, 2024

AI is transforming the way scientists design cancer drugs and vaccines, study how stars form, translate brain activity into speech and turn pollution into useful products.

AI Opens Door to Safe, Effective New Antibiotics to Combat Resistant Bacteria

Details
July 31, 2024

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.

Page 2 of 6

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

UT Austin logo

©

The University of Texas at Austin | Privacy Policy | Web Accessibility

Cockrell School of Engineering
College of Natural Sciences 
Dell Medical School
Resources
  • Contact Us
  • News

Give